Oppenheimer Sets PolyPid Price Target at $10 per Share
Oppenheimer initiated coverage of PolyPid at Outperform, according to the accompanying ratings-action report.
Oppenheimer initiated coverage of PolyPid at Outperform, according to the accompanying ratings-action report.